NSE / BSEHealthcare
₹523.00+1.65+0.32%
P/E32.9Mkt Cap₹2.45 K CrEV/EBITDA27.1

Vimta Labs Ltd.

P/E32.9Mkt Cap₹2.45 K CrEV/EBITDA27.1
Company Profile

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Valuation

Market Cap
₹0.00
Current Price
₹0
as of 16 Oct 2026
P/E Ratio
0.0x
P/B Ratio
0.0x
EV / EBITDA
0.0x
EV / Sales
0.0x
52W High
₹0
52W Low
₹0
Shares Out
0.00 Cr

Profitability

Operating Margin
0.0%
Net Profit Margin
0.0%
EBITDA Margin
0.0%

Returns

ROE
0.0%
ROCE
0.0%
ROIC %
—
ROA
0.0%
Dividend Payout
0.0%

Solvency

Current Ratio
0.0x
Debt / Equity
0.0x
Debt / Assets
0.0x
CFO / Net Profit
0.0x
Interest Coverage
0.0x

AI Summary

Indian Stock

Strengths1

  • Strong 5-year net profit CAGR of 42.4%

Concerns0

    Rule-based from financial data. Not advice.

    Price History▼ 24.52% over 1Y

    Monthly Returns

    Unlock Monthly Returns

    Available on Pro and Institutional plans.

    Sign up free

    Year-to-Date ROI

    Unlock Year-to-Date ROI

    Available on Pro and Institutional plans.

    Sign up free

    Historical Volatility

    Unlock Historical Volatility

    Available on Pro and Institutional plans.

    Sign up free

    Historical Performance

    Revenue, profitability, and cash flow trends (₹ Crores)

    Revenue (10Y)

    Operating Income (10Y)

    Net Profit (10Y)

    Operating Margin % (10Y)

    Dividend Payout % (10Y)

    Free Cash Flow (10Y)

    Growth Summary

    Latest fiscal year: Mar 2025

    Revenue₹344.00 Cr▲ 19.0%
    EBITDA Growth—
    Net Profit₹67.00 Cr▲ 63.4%
    Cash from Ops (CFO)—
    Free Cash Flow (FCF)—▼ 111.8%
    Revenue CAGR 5Y9.8%
    EBITDA CAGR 5Y22.2%
    Net Profit CAGR 5Y42.4%
    NP Growth 1Y63.4%

    Historical Growth

    Year-by-year revenue, profitability, and cash flow (₹ Crores, last 1 year)

    YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
    Mar 2025₹344.00 Cr—₹67.00 Cr——17.7%19.0%63.4%

    Showing the latest year only. Sign up free for the full history.

    Financial Statements

    Income statement, balance sheet, and cash flow (₹ Crores, as reported)

    Showing the latest year only. Sign up free for the full history.

    Consolidated Figures in USD Millions.

    Unnamed: 0TTM
    Revenue / Net Sales384
    Total Expenses250
    EBIT / Operating Profit134
    OPM %35%
    Other Income11
    Finance Costs2
    Depreciation & Amortisation39
    Profit Before Tax104
    Tax %-
    Net Profit / PAT79
    EPS (₹)17.67
    Dividend Payout %-

    Peer Comparison

    Healthcare sector peers, ranked by market cap

    CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
    Vimta Labs Ltd.this co.₹2.45 K Cr₹344.00 Cr32.905.8827.1019.0%
    Sun Pharmaceutical Industries Ltd.₹4.15 L Cr₹23.00 K Cr88.7017.4372.3013.5%
    Divi's Laboratories Ltd.₹1.71 L Cr₹9.20 K Cr67.9011.1367.2120.0%
    Torrent Pharmaceuticals Ltd.₹1.33 L Cr₹9.68 K Cr62.5015.7645.6413.5%
    Cipla Ltd.₹1.17 L Cr₹19.05 K Cr22.503.5119.3314.9%
    Apollo Hospitals Enterprises Ltd.₹1.05 L Cr₹8.20 K Cr75.0011.2854.4412.8%
    Max Healthcare Institute Limited₹1.00 L Cr₹2.66 K Cr144.0011.7696.8413.8%
    Industry Average—₹3.29 K Cr98.638.1165.5020.2%

    Learn while you research

    Hand-picked academy chapters to deepen your understanding of Vimta Labs Ltd. and the metrics that matter.

    Browse the full Equiscale Academy